Our news

  • Our ten most accessed reviews in 2020 (reviews published anytime) are shown below.Congratulations to everyone involved.1. Cannabis-based medicines for chronic neuropathic pain in adults (DOI: 10.1002/14651858.CD012182.pub2). See full review here. 2. Physical activity and exercise for chronic pain in adults: an overview of Cochrane...
    November 29 2021
  • Our top ten most cited reviews contributing to the 2020 Impact Factor (i.e. those published in 2018 and 2019, and cited in 2020) are shown below.Congratulations to everyone involved.1. Cannabis-based medicines for chronic neuropathic pain in adults (DOI: 10.1002/14651858.CD012182.pub2). See full review here. 2. Psychological...
    November 29 2021
  • This new review, Antiemetics for adults for prevention of nausea and vomiting caused by moderately or highly emetogenic chemotherapy: a network meta-analysis, was published in November  2021. We produced a blogshot as part of the dissemination plan. Link to the full review here. 
    November 25 2021
  • We are proud to announce that the 2020 equivalent Impact Factor for PaPaS is 11.276 (29 publications cited 327 times), maintaining the 2019 equivalent Impact Factor which was 11.446. This means that a review published by PaPaS in 2018 and 2019 was cited, on average, 11.276 times in 2020. Please note this is an unofficial metric calculated by Wiley...
    November 24 2021
  • We regularly send out newsletters to keep everyone updated on what Cochrane PaPaS has been doing recently. Please sign up to our newsletter here.Please click here to view our latest newsletter. See below for previous newsletters.Previous newslettersAugust 2021June 2021April 2021 February 2021December 2020October 2020August 2020June...
    October 21 2021
  • We were recently informed that all core NIHR infrastructure funding for UK Cochrane Review Groups would cease on 31 March 2023, which includes PaPaS. This is clearly disappointing news, and comes at a time when Cochrane itself is also undergoing significant change and re-organisation. We are busy investigating alternative funding...
    October 19 2021
  • This new review, Single-dose intravenous ibuprofen for acute postoperative pain in adults, was published in September 2021. We produced two blogshots as part of the dissemination plan. Link to the full review here. 
    October 4 2021
  • We are excited to share with you a brand new infographic for our project 'Optimal methods for the use of ‘pain’ as an outcome in systematic reviews of postoperative pain management'. This is a summary of the checklist which was produced to help to guide review authors and people who are using systematic reviews in this field towards...
    September 15 2021
  • This new review, Interventions for palliative symptom control in COVID-19 patients, was published in August 2021. We produced a blogshot as part of the dissemination plan. Link to the full review here. 
    September 6 2021
  • This newly updated review, Hydromorphone for cancer pain, was published in August 2021. We produced a blogshot as part of the dissemination plan. Link to the full review here.
    August 19 2021

Pages

Subscribe to Our news